SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q/A: (Original Filing)
[]
AUO [AU OPTRONICS] 6-K: (Original Filing)
[Item 1. AU Optronics Corp.]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q/A: (Original Filing)
[Explanatory Note No. 31.1 * 31.2 * 32.1 * 32.2 * 101.INS** XBRL Instance Document 101.SCH** XBRL Taxonomy Extensionhema Document 101.CAL** XBRL Taxonomy Extensionlculation Linkbase Document 101.DEF** XBRL Taxonomy Extension Definition Linkbase Document 101.LAB** XBRL Taxonomy Extension Labels Linkbase Document 101.PRE** XBRL Taxonomy Extension Presentation Linkbase DocumentYSTARBIO-PHARMACEUTICALCOMPANY September 13, 2012]
AUO [AU OPTRONICS] 6-K: Item 1. AU Optronics Corp.
[Item 1. AU Optronics Corp.]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 10-Q/A: Explanatory Note No. 31.1 * 31.2 * 32.1
[Explanatory Note No. 31.1 * 31.2 * 32.1 * 32.2 * 101.INS** XBRL Instance Document 101.SCH** XBRL Taxonomy Extensionhema Document 101.CAL** XBRL Taxonomy Extensionlculation Linkbase Document 101.DEF** XBRL Taxonomy Extension Definition Linkbase Document 101.LAB** XBRL Taxonomy Extension Labels Linkbase Document 101.PRE** XBRL Taxonomy Extension Presentation Linkbase DocumentYSTARBIO-PHARMACEUTICALCOMPANY September 13, 2012]
LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)
[CHINA LIFE INSURANCE COMPANY LIMITED (A joint stock limited company incorporated in the Peoples Republic of China with limited liability) (the Company) (Stock Code: 2628) ANNOUNCEMENT OF PREMIUM INCOME CIRC Reference is made to the Companys announcement dated 27 August 2004. The accumulated premium income of the Company for the period from 1 January 2012 to 31 August 2012 was] [Description 99.1 Announcement, dated September 13, 2012]
SMI [SEMICONDUCTOR MANUFACTURING INTERNATIONAL] 6-K: (Original Filing)
[CONTENTS 2 Additional Information 3 Corporate Information 4 Letter to Shareholders 6 Managements Discussion and Analysis of Financial Condition and Results of Operations 14 Corporate Governance Report 22 Other Information 31 Condensed Consolidated Statements of Comprehensive Income 32 Condensed Consolidated Balance Sheets 33 Condensed Consolidated Statements of Equity 34 Condensed Consolidated Statements of Cash Flows 35 Notes to the Condensed]
